A large European cross-sectional study has now examined which factors delay the diagnosis of axSpA. A major factor is the number and type of medical professionals who have assessed the patients.
Aug 11, 2020
0
1
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate reduced risk of venous thromboembolism and persistent pain, but increased risk of revision in partial versus ...
Jun 13, 2019
0
1
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that among individuals with radiographic knee osteoarthritis (OA), decreased physical performance and greater ...
Jun 14, 2018
0
2
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 has shown that Acceptance and Commitment Therapy, a form of cognitive behavioural therapy (CBT) that focuses on psychological ...
Jun 15, 2017
0
8
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) suggest that gout is associated with a 17-20% higher risk of dementia in the elderly.
Jun 15, 2018
0
0
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) showed that prolonged repetitive physical workload increases the risk of developing rheumatoid arthritis (RA). ...
Jun 10, 2016
2
1
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) showed that sexual dysfunction is present in more than one-third of patients with rheumatoid arthritis (RA) who ...
Jun 10, 2016
0
3
Two new studies presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) have helped clarify the relationship between the dietary intake of monounsaturated fatty acids and cholesterol with disease ...
Jun 11, 2014
0
0
Disease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases. A Belgian study has now concluded that early intensive treatment combining methotrexate with a bridging ...
Jun 17, 2020
0
3
The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug hydroxychloroquine for 24 weeks did ...
Jun 13, 2015
0
9
